Want to join the conversation?
$ACN posted higher earnings in 4Q16, helped by higher revenue compared to 4Q15. Net income was $1.13Bil or $1.68 per diluted share compared to $788MM or $1.15 per diluted share last year. Net revenue was $8.49Bil compared to $7.89Bil in 4Q15. Adjusted EPS was $1.31, a 14% increase from last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?